https://www.selleckchem.com/pr....oducts/AZD2281(Olapa
Previous trials suggest lower long-term risk of mortality after invasive rather than non-invasive management of patients with non-ST elevation myocardial infarction (NSTEMI), but the trials excluded very elderly patients. We aimed to estimate the effect of invasive versus non-invasive management within 3 days of peak troponin concentration on the survival of patients aged 80 years or older with NSTEMI. Routine clinical data for this study were obtained from five collaborating hospitals hosting NIHR Biomedical Research Centres